1. Home
  2. TXT vs INCY Comparison

TXT vs INCY Comparison

Compare TXT & INCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Textron Inc.

TXT

Textron Inc.

HOLD

Current Price

$87.89

Market Cap

15.9B

Sector

Industrials

ML Signal

HOLD

Logo Incyte Corp.

INCY

Incyte Corp.

HOLD

Current Price

$118.38

Market Cap

17.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TXT
INCY
Founded
1923
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Commercial Physical & Biological Resarch
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.9B
17.0B
IPO Year
1994
1994

Fundamental Metrics

Financial Performance
Metric
TXT
INCY
Price
$87.89
$118.38
Analyst Decision
Buy
Buy
Analyst Count
11
21
Target Price
$95.18
$103.52
AVG Volume (30 Days)
1.7M
1.8M
Earning Date
04-30-2026
04-28-2026
Dividend Yield
0.09%
N/A
EPS Growth
18.01
4173.33
EPS
2.67
1.47
Revenue
$14,799,000,000.00
$3,394,635,000.00
Revenue This Year
$5.87
$10.44
Revenue Next Year
$4.54
$10.99
P/E Ratio
$33.13
$81.50
Revenue Growth
8.01
13.67
52 Week Low
$76.93
$77.69
52 Week High
$101.57
$132.60

Technical Indicators

Market Signals
Indicator
TXT
INCY
Relative Strength Index (RSI) 47.78 53.59
Support Level $86.84 $93.60
Resistance Level $93.29 $119.29
Average True Range (ATR) 2.66 4.31
MACD -0.28 -0.64
Stochastic Oscillator 33.01 25.07

Price Performance

Historical Comparison
TXT
INCY

About TXT Textron Inc.

Textron is a conglomerate that designs, manufactures, and services a range of specialty aircraft including small jets, propeller-driven airplanes, helicopters, and tilt-rotor aircraft. Textron Aviation manufactures and services Cessna and Beechcraft planes. Bell is a helicopter and tilt-rotor manufacturer and servicer for both commercial and military customers. Textron Systems produces uncrewed aircraft and armored vehicles for the military market as well as aircraft simulators and training for the commercial and military markets. Textron Industrial houses the Kautex business, which manufactures plastic fuel tanks for conventional and hybrid motor vehicles, and other subsidiaries that produce specialized vehicles such as golf carts and all-terrain vehicles.

About INCY Incyte Corp.

Incyte focuses on the discovery and development of small-molecule drugs. The firm's leading drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis and 2022 for vitiligo. Incyte's pipeline includes a broad array of oncology and dermatology programs.

Share on Social Networks: